Effect of Lactobacillus casei Shirota on colonic transit time in patients with chronic constipation

Coloproctology

Volumn 33, Issue 2, 2011, Pages 109-113

  Krammer, H J ^a   Von Seggern, H ^a   Schaumburg, J ^b   Neumer, F ^a  

^a Praxis für Gastroenterologie und Ernährungsmedizin am End und Dickdarmzentrum Mannheim ^*  (Germany)

^b Yakult Deutschland GmbH   (Germany)

Author keywords

Clinical trial; Constipation; Probiotics; Shirota; Transit time

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ADULT; ARTICLE; BRISTOL STOOL FORM SCALE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DIGESTIVE FUNCTION; DOUBLE BLIND PROCEDURE; FEMALE; FERMENTED PRODUCT; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE TRANSIT TIME; LACTOBACILLUS CASEI; MILK; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECTUM; SIGMOID; STOOL FREQUENCY;

EID: 79959259585     PISSN: 01742442     EISSN: 1128045X     Source Type: Journal    
DOI: 10.1007/s00053-011-0177-0     Document Type: Article

References (24)

1. Lembo A, Camilleri M (2003) Chronic constipation. N Engl J Med 349:1360-1368
2. Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME (2008) Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol 8:5
3. Knowles CH, Martin JE (2000) Slow transit constipation: a model of human gut dysmotility. Review of possible aetiologies. Neurogastroenterol Motil 12:181-196
4. Bassotti G, Roberto GD, Sediari L, Morelli A (2004) Toward a definition of colonic inertia. World J Gastroenterol 10:2465-2467 (Pubitemid 39206760)
5. Malinen E, Rinttilä T, Kajander K et al (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with realtime PCR. Am J Gastroenterol 100:373-382 (Pubitemid 40314522)
6. Möllenbrink M, Bruckschen E (1994) Behandlung der chronischen Obstipation mit physiologischen Escherichia-coli-Bakterien. Ergebnisse einer klinischen Studie zur Wirksamkeit und Verträglichkeit der mikrobiologischen Therapie mit dem E.-coli-Stamm Nissle 1917 (Mutaflor® ). Med Klin 89:587-593
7. Krammer HJ, Kämper H, Bünau R von et al (2006) Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients. Z Gastroenterol 44:651-656 (German)
8. Koebnick C, Wagner I, Leitzmann P et al (2003) Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 17:655-659 (Pubitemid 37536846)
9. Heaton KW, Radvan J, Cripps H et al (1992) Defecation frequency and timing, and stool form in the general population: a prospective study. Gut 33:818-824
10. Agachan F, Chen T, Pfeifer J et al (1996) A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 39:681-685 (Pubitemid 26181138)
11. Svedlund J, Sjödin I, Dotevall G (1988) GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33:129-134 (Pubitemid 18054672)
12. Metcalf AM, Phillips SF, Zinsmeister AR et al (1987) Simplified assessment of segmental colonic transit. Gastroenterology 92:40-47 (Pubitemid 17207659)
13. Spanhaak S, Havenaar R, Schaafsma G (1998) The effect of milk fermented by Lactobacillus casei Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52:899-907 (Pubitemid 29008371)
14. Cummings JH (2001) Prebiotic digestion and fermentation. Am J Clin Nutr 73 (Suppl):415S-420S
15. Ohashi Y, Inoue R, Tanaka K et al (2001a) Lactobacillus casei Shirota-fermented milk stimulates indigenous lactobacilli in the pig intestine. J Nutr Sci Vitaminol (Tokyo) 47:172-176 (Pubitemid 32578279)
16. Malcolm A, Kellow JE (1997) Motility. Curr Opin Gastroenterol 13:117-123 (Pubitemid 27191046)
17. Roberfroid M (1993) Dietary fiber, inulin, and oligofructose: a review comparing their physiologic effects. Crit Rev Food Sci Nutr 33:103-148
18. Grider JR, Piland BE (2007) The peristaltic reflex induced by short-chain fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF. Am J Physiol Gastrointest Liver Physiol 292:G429-437
19. Ohashi Y, Inoue R, Tanaka K et al (2001b) Strain gauge force transducer and its application in a pig model to evaluate the effect of probiotic on colonic motility. J Nutr Sci Vitaminol (Tokyo) 47:351-356 (Pubitemid 33139562)
20. Clemens ET, Stevens CE, Southworth M (1975) Sites of organic acid production and pattern of digesta movement in the gastrointestinal tract of swine. J Nutr 105:759-768
21. Lewis SJ, Heaton KW (1997) Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 41:245-251 (Pubitemid 27395930)
22. Bouvier M, Meance S, Bouley C et al (2001) Effects of consumption of a milk fermented by the probiotic Bifidobacterium animalis DN 173 010 on colonic transit time in healthy humans. Bioscience Microflora 20:43-48
23. Marteau P, Cuillerier E, Meance S et al (2002) Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a doubleblind, randomized, controlled study. Aliment Pharmacol Ther 16:587-593 (Pubitemid 34214540)
24. Méance S, Cayuela C, Turchet P et al (2001) Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium probiotic strain DN-173 010 and yoghurt strains on gut transit time in the elderly. Microb Ecol Health Dis 15:15-22